VEGFA and age-related macular degeneration: Although anti-VEGF therapy is also used for retinal diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), patients are often treated with fewer injections in real-world clinical studies than in randomized clinical trials, resulting in inferior outcomes [3–6].